Lv7
3890 积分 2021-10-17 加入
Strategies to Address Low Drug Solubility in Discovery and Development
8天前
已完结
Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation
18天前
已完结
Innovative, combinatorial and high-throughput approaches to degrader synthesis
21天前
已完结
Identification of a Primary Target of Thalidomide Teratogenicity
23天前
已完结
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
23天前
已完结
What Is the Right Dose? The Elusive Optimal Biologic Dose in Phase I Clinical Trials
24天前
已完结
Impact of linker length on the activity of PROTACs
24天前
已完结
Target and tissue selectivity of PROTAC degraders
2个月前
已完结
CDK4 and CDK6 kinases: From basic science to cancer therapy
3个月前
已完结
Degrader-antibody conjugates
3个月前
已完结
皖公网安备34019202002308
